The FDA is announcing the availability of a draft guidance for industry entitled "Complementary and Alternative Medicine [CAM] Products and Their Regulation by the FDA." The draft guidance discusses when a CAM product is subject to the Federal Food, Drug, and Cosmetic Act or Public Health Service Act. Electronic comments may be submitted by April 30 to